ORIC Pharmaceuticals Inc

NASDAQ:ORIC   3:59:43 PM EDT
20.32
-0.92 (-4.33%)
Other Pre-Announcement

Oric Pharmaceuticals Announces Presentation Of Preclinical Data On Glucocorticoid Receptor Antagonist Overcoming Resistance To An Androgen Receptor Degrader At The 32Nd EortcNciAacr Symposium 20

Published: 10/09/2020 10:45 GMT
(ORIC) - Oric Pharmaceuticals Announces Presentation of Preclinical Data on Glucocorticoid Receptor Antagonist Overcoming Resistance to an Androgen Receptor Degrader at the 32nd Eortc-nci-aacr Symposium 2020.
Oric Pharmaceuticals Inc - Expects to Report Interim Data From One of Trials in First Half of 2021 and From Other Trial in Second Half of 2021.